Metavalent Stigmergy

How New Default Consensus Realities Instantiate

First Longevity Pill Entering Clinical Trials?

Technology Review reports:<blockquote>A novel group of drugs that target a gene linked to longevity could provide a way to turn back the clock on the diseases of aging. The compounds are 1,000 times more potent than resveratrol, the molecule thought to underlie the health benefits of red wine, and have shown promise in treating rodent models of obesity and diabetes.

Human clinical trials to test the compounds in diabetes are slated to begin early next year, according to Sirtris Pharmaceuticals, based in Cambridge, MA, which developed the drugs.</blockquote>

Written on December 2, 2007


}